6/21
09:31 am
pbh
Rating for PBH
Low
Report
Rating for PBH
6/21
09:31 am
pbh
Rating for PBH
Low
Report
Rating for PBH
6/21
07:50 am
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $93.00 price target on the stock, up previously from $65.00.
Medium
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $93.00 price target on the stock, up previously from $65.00.
6/21
07:50 am
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $93.00 price target on the stock, up previously from $65.00.
Medium
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $93.00 price target on the stock, up previously from $65.00.
5/21
03:04 pm
pbh
Rating for PBH
Low
Report
Rating for PBH
5/16
03:15 pm
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its "neutral" rating re-affirmed by analysts at DA Davidson. They now have a $65.00 price target on the stock.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its "neutral" rating re-affirmed by analysts at DA Davidson. They now have a $65.00 price target on the stock.
5/16
03:15 pm
pbh
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its "neutral" rating re-affirmed by analysts at DA Davidson. They now have a $65.00 price target on the stock.
Low
Report
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its "neutral" rating re-affirmed by analysts at DA Davidson. They now have a $65.00 price target on the stock.
5/16
02:35 pm
pbh
Rating for PBH
Low
Report
Rating for PBH
5/16
02:35 pm
pbh
Rating for PBH
Low
Report
Rating for PBH